Other Publication Details
Mandatory Fields
Meeting
Conneally, E,Swords, RT,Giles, FJ,McMullin, MF,le Coutre, P,Langabeer, S,Wieczorkowska, M,McDowell, C,Moulton, B,Egan, K,O'Dwyer, M
2010
November
Nilotinib 300 Mg Twice Daily as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia In Chronic Phase: Updated Results of the ICORG 0802 Phase 2 Study with Analysis of the GeneXpert System Versus IS BCR-ABL RQ PCR
Published
1
Optional Fields
1404
1404
Grant Details
Publication Themes